The Middle East Cancer Consortium (MECC) was established through an official agreement of the Ministries of
Health of Cyprus, Egypt, Israel, Jordan, and the Palestinian Authority. The agreement was signed in Geneva in May 1996.
Turkey officially joined the Consortium in June 2004.
The objective of the MECC is to reduce the incidence and impact of cancer in the Middle East through the
solicitation and support of collaborative research. Since its inception, MECC’s major activities have been the
Cancer Registry Project (CRP), the Small Grants Programme, and the Palliative Care Project (PCP).
The CRP aims to support population-based cancer registries within MECC members and develop linkages
among them. The Small Grants Programme enabled clinicians and scientists within MECC signatories to
submit research proposals for funding. All proposals were peer-reviewed for their scientific merit and must involve
collaboration between more than one participating MECC member.
Click on the links to the left to learn more about MECC’s history, governance, and participants.